|  |  | Number with MCII (%) | |
---|---|---|---|---|
Variables | Pearson's χ2 | Pvalues | OAK | Control |
Preintervention to 8 weeks | Â | Â | Â | Â |
   WOMAC Physical Function, absolute | 10.84(1, 141) | P = 0.001 | 25 (37%) | 9 (13%) |
   WOMAC Physical Function (%) | 19.34(1, 141) | P ≤ 0.001 | 29 (43%) | 7 (10%) |
   SF-36 Physical Function | 8.34(1, 140) | P = 0.006 | 40 (60%) | 23 (34%) |
   SF-36 Pain | 1.38(1, 139) | P = 0.265 | 23 (34%) | 17 (25%) |
   VAS Pain, absolute | 15.95(1, 139) | P ≤ 0.001 | 27 (40%) | 7 (10%) |
   VAS Pain (%) | 17.37(1, 139) | P ≤ 0.001 | 25 (37%) | 5 (7%) |
   TUG | 28.87(1, 139) | P ≤ 0.001 | 46 (69%) | 15 (22%) |
   Responders | 13.59(1, 141) | P ≤ 0.001 | 26 (39%)b | 8 (12%)b |
Preintervention to 6 months | Â | Â | Â | Â |
   WOMAC Physical Function, absolute | 3.87(1, 135) | P = 0.057 | 24 (14%) | 14 (20%) |
   WOMAC Physical Function (%) | 4.37(1, 135) | P = 0.043 | 27 (40%) | 15 (22%) |
   SF-36 Physical Function | 2.93(1, 136) | P = 0.122 | 40 (60%) | 29 (43%) |
   SF-36 Pain | 0.95(1, 135) | P = 0.384 | 31 (46%) | 25 (37%) |
   TUG | 5.10(1, 132) | P = 0.036 | 38 (57%) | 26 (38%) |
   Responders | 2.58(1, 135) | P = 0.123 | 22 (33%)b | 14 (20%)b |